| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |